In adenocarcinoma cells, the expression level of TRIM29 is more than 20 times higher than that of normal pancreatic and chronic pancreatitis cells, which suggests that TRIM29 is a good biomarker [12]. This evidence concerns the gene TRIM29 and adenocarcinoma.